Surgery Partners, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Surgery Partners, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2014 to Q3 2024.
  • Surgery Partners, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $4.5M, a 45.2% increase year-over-year.
  • Surgery Partners, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $19.8M, a 450% increase year-over-year.
  • Surgery Partners, Inc. annual Income Tax Expense (Benefit) for 2023 was -$300K, a 101% decline from 2022.
  • Surgery Partners, Inc. annual Income Tax Expense (Benefit) for 2022 was $23.3M, a 122% increase from 2021.
  • Surgery Partners, Inc. annual Income Tax Expense (Benefit) for 2021 was $10.5M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $19.8M $4.5M +$1.4M +45.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $18.4M $4.9M +$12.7M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $5.7M $4.4M +$6M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$300K $6M -$3.9M -39.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $3.6M $3.1M -$4.7M -60.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $8.3M -$7.8M -$12.1M -281% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $20.4M -$1.6M -$2.9M -223% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $23.3M $9.9M -$1.9M -16.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $25.2M $7.8M +$6.6M +550% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $18.6M $4.3M +$7M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $11.6M $1.3M +$1.1M +550% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $10.5M $11.8M +$17.4M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 -$6.9M $1.2M -$100K -7.69% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$6.8M -$2.7M -$2.1M -350% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 -$4.7M $200K +$15.4M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$20.1M -$5.6M -$10M -227% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$10.1M $1.3M -$1.1M -45.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$9M -$600K -$1.6M -160% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$7.4M -$15.2M -$16.9M -994% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $9.5M $4.4M -$11.1M -71.6% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $20.6M $2.4M -$3.4M -58.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $24M $1M -$2.3M -69.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $26.3M $1.7M -$100K -5.56% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $26.4M $15.5M -$56.2M -78.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-10
Q3 2018 $82.6M $5.8M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $3.3M +$2.79M +545% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $1.8M -$317K -15% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $71.7M +$67.1M +1459% Sep 1, 2017 Dec 31, 2017 10-K 2020-03-13
Q2 2017 $5.53M $512K -$1.91M -78.8% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $7.44M $2.12M +$347K +19.6% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $7.1M $4.6M +$162M Oct 1, 2016 Dec 31, 2016 10-K 2017-03-10
Q3 2016 -$155M -$1.69M -$5.61M -143% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-10
Q2 2016 -$149M $2.42M +$76K +3.24% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$149M $1.77M -$337K -16% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$149M -$157M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 $3.92M -$4.04M -50.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $2.34M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $2.11M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q3 2014 $7.96M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.